All Stories

  1. Oral Agents and SARS-CoV-2 Vaccine Effectiveness Against Severe COVID-19 Omicron Events in Maintenance Dialysis Patients
  2. Calciphylaxis-as a drug induced adverse event
  3. Integrated Pharmacy Services: A Necessary Component for Care of Patients Treated by Long-term Dialysis
  4. Medication Reconciliation and Therapy Management in Dialysis-Dependent Patients: Need for a Systematic Approach
  5. Medication-related Problems in CKD
  6. Correlation between the renal quality of life profile and short form-36 in a United States hemodialysis population
  7. Health-related quality of life is maintained in hemodialysis patients receiving pharmaceutical care: A 2-year randomized, controlled study
  8. Treatment and costs associated with anemic chronic kidney disease patients
  9. Treatment and costs associated with anemic chronic kidney disease patients
  10. Treatment of hypertension and diabetes mellitus in patients with chronic kidney disease: a review
  11. Vancomycin Use in Patients Requiring Hemodialysis: A Literature Review
  12. Undertreatment of Anemia in Patients with Chronic Kidney Disease in the United States: Analysis of National Outpatient Survey Data
  13. Medication-Related Problems in Ambulatory Hemodialysis Patients: A Pooled Analysis
  14. Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitrostudy
  15. Medication-related problem type and appearance rate in ambulatory hemodialysis patients
  16. Thiazolidinedione Safety and Efficacy in Ambulatory Patients Receiving Hemodialysis
  17. Gentamicin pharmacokinetics during slow daily home hemodialysis
  18. Comment: Medicaid prescriber compliance with Joint National Committee VI hypertension treatment guidelines
  19. Comment: Medicaid prescriber compliance with Joint National Committee VI hypertension treatment guidelines
  20. Automated Peritoneal Dialysis Symposium: Treatment of Peritonitis in APD: Pharmacokinetic Principles
  21. Darbepoetin-α: A Review of the Literature
  22. The Clinical and Economic Impact of Pharmaceutical Care in End‐Stage Renal Disease Patients
  23. Prediction and Prevention of Contrast Nephropathy
  24. Respiratory Distress Caused by Salicylism Confirmed by Lung Biopsy